Black Diamond Therapeutics, Inc. Common Stock (BDTX) is a publicly traded Healthcare sector company. As of August 5, 2026, BDTX trades at $1.78 with a market cap of $102.00M and a P/E ratio of 4.55. BDTX moved +0.00% today. Year to date, BDTX is -26.34%; over the trailing twelve months it is -34.43%. Its 52-week range spans $1.20 to $4.94. Analyst consensus is strong buy with an average price target of $11.00. Rallies surfaces BDTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for BDTX shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $1.78 |
| Market Cap | $102.00M |
| P/E Ratio | 4.55 |
| EPS | $0.39 |
| Dividend Yield | 0.00% |
| 52-Week High | $4.94 |
| 52-Week Low | $1.20 |
| Volume | 328.65K |
| Avg Volume | 0 |
| Revenue (TTM) | $70.00M |
| Net Income | $22.37M |
| Gross Margin | 0.00% |
4 analysts cover BDTX: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $11.00.